Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials Recent advances in machine ...
Unveiled November 10, ML.NET 2.0 arrived in tandem with a new version of the ML.NET Model Builder, a visual developer tool for building machine learning models for .NET applications. The Model Builder ...
There is ongoing clinical need to improve estimates of disease outcome in prostate cancer. Machine learning (ML) approaches to pathologic diagnosis and prognosis are a promising and increasingly used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback